Statins in Elderly

Statins in Elderly

  • The CV event rates in elderly subjects are proportionately higher than for younger subjects in primary and secondary prevention studies emphasizing increased absolute risk.
  • Multimorbidity, frailty, dementia and polypharmacy can affect the efficacy, safety and compliance with statin therapy among elderly patients. The decision to use statins for primary CV prevention in very old patients remains unclear, and a decision must be made on a case-to-case basis.
  • For secondary prevention, statin therapy is generally recommended except for those with severely impaired health, extreme frailty or a short life expectancy.

Dr. Kunal Mahajan

Dr. Kunal Mahajan is a Director and Chief Interventional Cardiologist, Himachal Heart Institute, Mandi, HP India. He Completed MBBS from RPGMC Tanda at Kangra HP (2002-2008). MD (Medicine) from Pt. B.D.Sharma PGIMS Rohtak Haryana (2010-2013). DM (Cardiology) from IGMC Shimla HP (2014-2017). Dr. Kunal Mahajan previously served as an assistant professor in the department of Cardiology at IGMC Shimla for more than 2 years and as a senior interventional cardiologist in Holy Heart Hospital Rohtak Haryana for more than 3 years.


Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks